Welcome to the e-CCO Library!

P222: Diagnostic accuracy of ultrasonography in the detection of postsurgical recurrence in Crohn’s disease: A systematic review with meta-analysis
Year: 2018
Source: ECCO '18 Vienna
Authors:

N. Imperatore*, A. Rispo, A. Testa, O.M. Nardone, N. Caporaso, F. Castiglione

Created: Thursday, 21 February 2019, 9:14 AM
P222: Heart rate variability is a predictor to disease exacerbation in paediatric Inflammatory Bowel Disease
Year: 2021
Source: ECCO'21 Virtual
Authors: Yerushalmy-Feler, A.(1);Cohen, S.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P222: Purely fibrostenotic Crohn’s disease without chronic inflammation is uncommon – a histopathologic study of resected intestine
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

U. N. Shivaji*1,2, M. Evans3, T. Critchlow4, S. C. L. Smith2, M. Iacucci1,2, S. Ghosh1,2, R. Cooney4, K. Skordilis3

Created: Friday, 22 February 2019, 9:41 AM
P222: Raman Spectroscopy in the diagnosis of pIBD: experimental study
Year: 2022
Source: ECCO'22
Authors: Viola, I.(1);Costa, S.(1);Pellegrino , S.(1);Acri, G.(2);Romano, C.(1);
Created: Friday, 11 February 2022, 3:52 PM
P222: Sequential MRI volume measurements of perianal fistulae in Crohn's disease
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Black C.*1, Razack A.2, Sebastian S.1,2

Created: Wednesday, 20 February 2019, 10:36 AM
P222: The onset of clinical manifestations in patients with inflammatory bowel disease
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

V. Nóbrega1, J. Silva1, B. Brito1, I. Silva1, M. C. Silva1, A. Pimentel2, F. Fortes2, B. C. da Silva*3, 4, N. Almeida2, N. Almeida2, V. Surlo2, J. Mota2, G. Santana1

Created: Friday, 22 February 2019, 9:49 AM
P223 Oesophagal involvement is a predictor of anti-TNF treatment failure in patients with Crohn’s disease
Year: 2020
Source:

ECCO'20 Vienna

Authors:

Y. Sakata, N. Tsuruoka, M. Esaki

Created: Thursday, 30 January 2020, 10:12 AM
P223: Bowel damage in Crohn’s disease: direct comparison of ultrasonography– and magnetic resonance–based Lemann index
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

N. Imperatore*1, A. Rispo1, A. Testa1, P. Mainenti2, G. D. De Palma1, M. Rea1, O.M. Nardone1, G. Luglio1, P. Gervetti1, M. L. Taranto1, F. Castiglione1

Created: Friday, 22 February 2019, 9:49 AM
P223: C-reactive protein improvement after vedolizumab induction phase is associated with remission after 6 months of treatment in ulcerative colitis patients
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Zezos P.*1, Kabakchiev B.2, Weizman A.V.1, Nguyen G.C.1, Narula N.1, Croitoru K.1, Steinhart A.H.1, Silverberg M.S.1

Created: Wednesday, 20 February 2019, 10:36 AM
P223: Day of admission results predict outcome in acute ulcerative colitis
Year: 2018
Source: ECCO '18 Vienna
Authors:

R. Grant1, R. Lynch1, T. Manship2, F. Jagger3, G.-T. Ho3, C. Lees3, J. Satsangi3, I. Arnott3*

Created: Thursday, 21 February 2019, 9:14 AM
P223: Degree of Histological Activity is not Associated with Vedolizumab Therapy Outcome in Ulcerative Colitis
Year: 2021
Source: ECCO'21 Virtual
Authors: Doherty, J.(1);Brennan, S.(2);Dinneen, K.(2);Muldoon, C.(2);Mc Kiernan, S.(1);Dunne, C.(1);Mac Carthy, F.(1);Hartery, K.(1);Ciara, R.(2);Kevans, D.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P223: Efficacy and safety of tacrolimus in Crohn’s disease: a nationwide, multi-centric study from GETECCU
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

I. Rodriguez-Lago*1, J. Castro-Poceiro2, A. Fernández-Clotet2, F. Mesonero3, A. López-Sanromán3, A. López-García4, L. Márquez4, A. Clos-Parals5, F. Cañete5, M. Vicuña6, Ó. Nantes6, O. Merino7, V. Matallana Royo8, J. Gordillo9, A. Elorza1, P. Sanz10, M. J. Casanova11,12, R. Ferreiro-Iglesias13, P. Pérez-Galindo14, J. M. Benítez15,16, C. Taxonera17, M. J. García García18, E. Martín Arranz19, M. Calafat20, A. Martín-Cardona21,22, F. Muñoz Núñez23, J. O. Miquel-Cusachs24, E. Sáinz Arnau25, J. P. Gisbert11, Young IBD Group from GETECCU1

Created: Friday, 22 February 2019, 9:41 AM
P223: Neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in patient with intestinal Behçet’s disease as a marker of disease activity and prognosis
Year: 2022
Source: ECCO'22
Authors: Jung, B.W.(1);Kang, E.A.(1);Park, S.J.(1);Park, J.J.(1);Cheon, J.H.(1);Kim, T.I.(1);Park, J.(1);
Created: Friday, 11 February 2022, 3:52 PM
P223: The usefulness of tissue calprotectin in pediatric Crohn's disease – a pilot study.
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Szymanska, E.(1)*;Szymanska, S.(2);Karkucinka-Wieckowska, A.(3);Aldona, W.(4);Kierkus, J.(5);Dadalski, M.(6);
Created: Friday, 14 July 2023, 10:48 AM
P224 Crohn’s disease experiences among a paediatric population: A qualitative study reviewing the agreement of symptoms discussed by children and adolescents
Year: 2020
Source:

ECCO'20 Vienna

Authors:

U. Coskun1, K. Kelly1, T. Hunter2, L. Newton3, T. Symonds3, L. Delbecque4

Created: Thursday, 30 January 2020, 10:12 AM
P224: Deconstructing distress: Stakeholder engagement for evidence-based, patient-centered interventions for the management of IBD-associated psychological distress
Year: 2022
Source: ECCO'22
Authors: Heisler, C.G.(1);Rohatinsky, N.(2);Stewart, M.(3);Vallis, M.(4);Shepherd, T.(5);Wozney, L.(6);Cassidy, C.(7);Currie, B.(1);Phalen-Kelly, K.(8);Robar, J.(1);Targownik, L.(9);Huard, T.(10);Neil, E.(10);Jones, J.(3);
Created: Friday, 11 February 2022, 3:52 PM
P224: Diagnostic delay in inflammatory bowel disease is not associated with difficult access to healthcare facilities: a clinical study on incidental cases
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Cantoro, L.(1)*;Monterubbianesi, R.(1);Camastra, C.(1);Falasco, G.(1);Pantanella, P.(1);Cosintino, R.(1);Faggiani, R.(1);Fiorino, G.(1,2);
Created: Friday, 14 July 2023, 10:48 AM
P224: Primary sclerosing cholangitis in the Swiss Inflammatory Bowel Disease Cohort: prevalence, risk factors, and long-term follow-up
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

M. Fraga*1, N. Fournier2, E. Safroneeva3, V. Pittet4, A. Nydegger5, S. Vavricka6, D. Moradpour1, A. Schoepfer1

Created: Friday, 22 February 2019, 9:49 AM
P224: Regular physical activity on IBD patients: impact on IBD natural history and related comorbidities
Year: 2021
Source: ECCO'21 Virtual
Authors: Arias-Loste, M.T.(1);Salcines, L.(2);Rodriguez-Duque, J.C.(1);García García, M.J.(1);Iruzubieta, P.(1);Rivas, C.(1);Castro, B.(1);Rivero, M.(1);Crespo, J.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P224: Relationship of faecal calprotectin and long-term outcomes in Finnish adult patients with Crohn’s disease: Retrospective multi-centre chart review study
Year: 2018
Source: ECCO '18 Vienna
Authors:

T. Hallinen1, A. Jussila2, C.-G. af Björkesten3, H. Kemppainen4, E. Soini1, P. Mankinen1, S. Valgarðsson5, V. Veckman6, R. Nissinen6, P. Molander7*

Created: Thursday, 21 February 2019, 9:14 AM